Gram Research analysis found that a genetic variant in the ATP7B gene predicted slower copper removal in Labrador retrievers treated with D-penicillamine, with each copy slowing the monthly drop in liver copper by about 76 mg per kg. The variant was also linked to much lower odds of normalizing liver copper on a low-copper diet. These findings are exploratory.
Copper buildup in the liver is a serious problem for Labrador retrievers, and treatment times vary widely from dog to dog. According to research reviewed by Gram, a genetic variant in the ATP7B gene was linked to slower copper removal in dogs taking D-penicillamine, a common drug for this condition. Dogs with this variant were also less likely to bring their liver copper down to normal levels on a low-copper diet. The researchers reanalyzed three earlier studies involving 87 dogs. A second gene variant, ATP7A, showed a weaker link to faster copper removal that did not reach standard statistical significance. The authors describe these results as exploratory, meaning larger studies are needed before genetic testing can guide treatment decisions.
Key Statistics
A 2026 reanalysis of three earlier studies involving 87 Labrador retrievers found that each copy of the ATP7B:c.4358G>A variant was associated with a liver copper decline about 76 mg/kg dry weight per month slower during D-penicillamine treatment.
In a 2026 analysis of 28 Labrador retrievers with early copper buildup, the ATP7B:c.4358G>A variant was associated with odds about 13 times higher of failing to normalize liver copper on a copper-restricted diet, though the confidence interval was wide.
The same 2026 reanalysis reported that the ATP7A:c.980C>T variant showed a non-significant trend toward faster copper removal of about 73 mg/kg dry weight per month, a result the authors say needs confirmation.
The Quick Take
- What they studied: Researchers asked whether two specific genetic variants in Labrador retrievers help explain why some dogs with copper buildup in the liver respond faster or slower to treatment.
- Who participated: The team combined data from three earlier studies of Labrador retrievers with copper-related liver disease. One group had 43 dogs on D-penicillamine, a second had 28 dogs with early copper buildup on a low-copper diet, and a third had 16 dogs that had already responded to treatment.
- Key finding: In dogs taking D-penicillamine, each copy of the ATP7B variant was linked to a slower drop in liver copper of about 76 mg per kg of dry liver weight per month. The range of likely values was wide, roughly 29 to 123, so the true effect is uncertain.
- What it means for you: Genetic testing might someday help vets set expectations and choose treatment plans for individual dogs. For now, these results are early findings and should not change any treatment without guidance from a veterinarian.
The Research Details
This study did not recruit new dogs. Instead, the researchers went back to three earlier studies and looked at them again, this time including each dog’s genetic results. Their goal was to see whether genetic differences could explain why dogs with the same condition improved at different speeds.
The first earlier study was a retrospective study, meaning it looked back at past medical records. It tracked how liver copper levels changed over time in 43 dogs taking D-penicillamine, a drug that helps the body remove excess copper. The researchers also considered each dog’s diet in this group.
The other two earlier studies were prospective, meaning dogs were followed forward in time. In these studies, dogs ate a diet low in copper, and their liver copper levels were measured. One group had 28 dogs with early copper buildup, and the other had 16 dogs that had already been successfully treated. Statistical models were then updated to include each dog’s genetic variants.
Reanalyzing existing data is a practical way to explore new questions without starting from scratch. It lets researchers test a idea across several groups of dogs, which can show whether a pattern appears more than once. However, because the study reused data that was collected for other purposes, it cannot prove cause and effect. It is best seen as a step toward a more focused study.
The study uses established statistical methods and reports confidence intervals, which show the range of likely true values. Several findings have wide intervals, meaning the exact size of the effect is uncertain. The authors label the work as exploratory, which signals that the results are a starting point rather than final proof. The sample sizes are small, and the data came from only one dog breed, so the results may not apply to other breeds or to dogs with different backgrounds.
What the Results Show
Among dogs taking D-penicillamine, the ATP7B variant was associated with a slower decline in liver copper. Each copy of the variant was linked to a drop that was about 76 mg per kg of dry liver weight per month smaller than dogs without it. This result was statistical significance, meaning it was unlikely to be due to chance alone.
In dogs with early copper buildup who were fed a low-copper diet, the same ATP7B variant was linked to much higher odds of failing to bring liver copper back to normal. The odds ratio was 13.0 per copy of the variant, which means the odds were about 13 times higher. The confidence interval was very wide, from about 2.2 to 255.4, so this number should be read as a strong signal that needs confirmation rather than a precise estimate.
The second variant, ATP7A, showed a trend toward faster copper removal in dogs taking D-penicillamine. The effect was about 73 mg per kg per month faster, but the result did not reach the usual threshold for statistical significance. The authors note that this link is weaker and needs more evidence.
The researchers also looked at diet in the D-penicillamine group, since diet can affect how much copper a dog takes in. Their models were adjusted to account for this, which helps make the genetic comparisons fairer. The authors stress that these secondary adjustments do not change the main conclusion, but they are one more reason to interpret the results carefully. The broader message is that genetic differences may help explain why treatment duration varies so much from one dog to the next.
Veterinarians have long noticed that Labrador retrievers with copper-related liver disease respond very differently to the same treatment. Earlier work had already linked copper-handling genes to the amount of copper stored in the liver. This study extends that work by testing whether those same genes predict how quickly dogs respond to treatment. The findings fit the broader picture that copper-related liver disease in these dogs has a genetic component.
The most important limitation is that this was a reanalysis of three existing studies rather than a new trial designed to test the genetic question. The number of dogs was small, which makes results less stable. Some confidence intervals were very wide, meaning the true size of the effects is uncertain. The ATP7A finding did not reach statistical significance. The study included only Labrador retrievers, so the results may not apply to other breeds. Finally, the study shows an association between genes and treatment response, not proof that the genes directly cause the differences.
The Bottom Line
Based on this exploratory study, the ATP7B variant appears to be linked to slower copper removal and a lower chance of normalizing liver copper on a low-copper diet. Confidence in this finding is moderate, since it comes from a small, reanalyzed dataset. The ATP7A finding has low confidence at this stage. Owners should not change treatment based on these results alone. Instead, they should discuss the findings with a veterinarian, who can weigh them alongside each dog’s full health picture.
This research is most relevant to owners of Labrador retrievers diagnosed with copper-associated hepatitis, and to veterinarians who treat this condition. It is less relevant to owners of healthy dogs or dogs of other breeds, since the study did not include them. People interested in human nutrition or human copper disorders should not apply these findings directly, because the research was done in dogs.
These findings are early, so no immediate changes to standard care are expected. If future studies confirm the link, genetic testing could become a routine tool within several years, but that timeline depends on new research, regulatory steps, and clinical adoption. Any individual dog’s treatment response will still take months, as copper removal from the liver typically happens gradually.
Frequently Asked Questions
Can genetic testing tell me how fast my Labrador will recover from copper buildup?
Not yet. A 2026 exploratory study linked the ATP7B variant to slower copper removal in 43 dogs taking D-penicillamine. The authors say larger prospective studies are needed before genetic testing can reliably guide treatment decisions for individual dogs.
What causes copper to build up in Labrador retriever livers?
Copper-associated hepatitis in Labrador retrievers is linked to how the body handles copper. Genes such as ATP7B and ATP7A help move copper out of the liver. Variants in these genes may reduce that removal, leading to copper accumulation over time.
How is copper buildup in Labrador retrievers usually treated?
Treatment typically combines a copper-restricted diet with D-penicillamine, a drug that helps the body remove excess copper. Response times vary widely. A 2026 study found that genetic differences may partly explain this variation, though more research is needed.
Should I change my Labrador’s diet based on the ATP7B gene study?
Do not change your dog’s diet based on this study alone. The research was exploratory and reanalyzed data from 87 dogs. Talk with your veterinarian about copper-restricted feeding plans and how to track liver test results over time.
Want to Apply This Research?
- Log each dog’s copper-restricted meals, treats, and supplements daily, and record the total in milligrams of copper if the food label provides it. Add liver test results and veterinary visit dates so changes can be compared over time.
- Help owners choose low-copper foods and avoid copper-rich treats such as liver, shellfish, and some supplements, but only as directed by the veterinarian. Remind owners to give medications on schedule and to keep scheduled bloodwork appointments.
- Build a long-term record that includes diet logs, medication doses, liver test results, and any genetic test results the vet provides. Review trends every few months with the veterinarian, and flag any gaps in testing or sudden changes in appetite, energy, or weight for prompt attention.
This article summarizes an exploratory research study in Labrador retrievers and is for general information only. It is not veterinary advice and should not replace guidance from a licensed veterinarian. Do not start, stop, or change any medication or diet for your dog based on this summary. Consult your veterinarian about your dog’s specific condition and treatment options.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.